<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="367206">
  <stage>Registered</stage>
  <submitdate>3/10/2014</submitdate>
  <approvaldate>24/11/2014</approvaldate>
  <actrnumber>ACTRN12614001228673</actrnumber>
  <trial_identification>
    <studytitle>Effect of the dietary supplement Satisfax (Registered Trademark) on weight loss in overweight volunteers.</studytitle>
    <scientifictitle>Effect of the dietary supplement Satisfax (Registered Trademark) on weight loss in overweight volunteers.</scientifictitle>
    <utrn>U1111-1160-5611</utrn>
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Overweight/obesity</healthcondition>
    <conditioncode>
      <conditioncode1>Diet and Nutrition</conditioncode1>
      <conditioncode2>Obesity</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Intervention with Satisfax (Registered Trademark), a proprietary blend of grape and kiwifruit extract, 3 times a day prior to meals at a dose of of 2 capsules (1 gram).  The treatment will be administered for 8 weeks via an oral capsule.  Adherence to the treatment regime will be monitored by capsule bottle return and self reporting on line.</interventions>
    <comparator>No treatment.  The participant's weight during the intervention will be compared to their weight immediately prior to the intervention.</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Body weight recorded on calibrated scales.</outcome>
      <timepoint>Eight weeks</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Acceptability of the treatment assessed by participants completing a 5 point Likert Scale.</outcome>
      <timepoint>8 weeks</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Compliance with prescribed dose assessed by participants returning their capsule bottles and the remaining capsules counted and recorded.</outcome>
      <timepoint>8 weeks</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Nil</outcome>
      <timepoint>Nil</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>BMI between 25 and 35</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>60</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Diabetic, pregnant or breast feeding</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment>Allocation is not concealed</concealment>
    <sequence>None</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods>Baseline demographic and clinical information will be summarized using standard descriptive statistics including means, medians, standard deviations, ranges, frequencies and percentages. Changes in outcomes will be analysed using paired t-tests with a two-tailed p-value &lt;0.05 considered statistically significant.  The primary analyses will be undertaken on all completing participants but analyses will also explore weight changes in those participants who exit the study early.  Clinical trials demonstrating weight loss by a similar mechanism as is hypothesised for the NZ Extracts product have seen significant changes with 20-60 participants over an 8 week period.  For this trial it is intended to recruit 100 participants with the aim that a least 60 will complete the trial.  A sample size of 60 will enable an effect size for weight change of &gt;0.4 to be detected as statistically significant (two-sided a=0.05) with greater than 80% power.</statisticalmethods>
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 0</phase>
    <anticipatedstartdate>13/10/2014</anticipatedstartdate>
    <actualstartdate>21/10/2014</actualstartdate>
    <anticipatedenddate>25/10/2014</anticipatedenddate>
    <actualenddate>24/10/2014</actualenddate>
    <samplesize>100</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up continuing</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Marlborough</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>New Zealand Extracts Ltd</primarysponsorname>
    <primarysponsoraddress>30 Maxwell Rd
Blenheim 7240</primarysponsoraddress>
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Tuatara Natural Products Ltd</fundingname>
      <fundingaddress>30 Maxwell Rd
Blenheim 7240</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Callaghan Innovation
</fundingname>
      <fundingaddress>69 Gracefield Road
PO Box 31310
Lower Hutt 5040
</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The primary purpose of this trial is to measure the acceptability of, and compliance with regular consumption of the health supplement Satisfax and its effect on body weight in overweight volunteers over a period of 8 weeks.  We hypothesize that the regular consumption of Satisfax will lead to a loss of weight in overweight volunteers.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Health and Disability Ethics Committees</ethicname>
      <ethicaddress>c/- MEDSAFE
Level 6
Deloitte House
10 Brandon St
Wellington 6011</ethicaddress>
      <ethicapprovaldate>1/10/2014</ethicapprovaldate>
      <hrec>14/STH/144</hrec>
      <ethicsubmitdate>27/08/2014</ethicsubmitdate>
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Glenn Vile</name>
      <address>New Zealand Extracts Ltd
PO Box 549
Blenheim 7240</address>
      <phone>+64 21 734 706</phone>
      <fax />
      <email>glenn@nzextracts.com</email>
      <country>New Zealand</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Glenn Vile</name>
      <address>New Zealand Extracts Ltd
PO Box 549
Blenheim 7240</address>
      <phone>+64 21 734 706</phone>
      <fax />
      <email>glenn@nzextracts.com</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Glenn Vile</name>
      <address>New Zealand Extracts Ltd
PO Box 549
Blenheim 7240</address>
      <phone>+64 21 734 706</phone>
      <fax />
      <email>glenn@nzextracts.com</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>